TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31

Tilray Brands, Inc.

Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026

$3.03−0.01 (-0.33%)

Close on Oct 19, 2026

Community

Notes and questions about Tilray Brands from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Tilray Brands's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Jan 8, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TLRY.

Revenue growth15.9% · median 1.5%

Gross margin29.1% · median 42.3%

Operating margin-9.3% · median -39.6%

Advertisement
300 × 250